IU GI FACULTY – PUBLICATIONS LAST 5 YEARS

IU GI FACULTY – PUBLICATIONS LAST 5 YEARS

Mohammad Al-Haddad

1. Al-Haddad M, Wallace MB, Woodward TA, Gross SA, Hodgens CM, Toton RD, Raimondo M. The safety of fine-needle aspiration guided by endoscopic ultrasound: a prospective study.Endoscopy. 2007 Dec 4;.

2. Al-Haddad M, Craig CA, Odell J, Pajaro O, Wallace MB. The use of self-expandable plastic stents for non-malignant esophago-pleural fistulas.Dis Esophagus. 2007;20(6):538-41.

3. Pungpapong S, Noh KW, Woodward TA, Wallace MB, Al-Haddad M, Raimondo M. Endoscopic ultrasound and IL-8 in pancreatic juice to diagnose chronic pancreatitis.Pancreatology. 2007;7(5-6):491-6.

4. Wallace MB, Woodward TA, Raimondo M, Al-Haddad M, Odell JA. Transaortic fine-needle aspiration of centrally located lung cancer under endoscopic ultrasound guidance: the final frontier.Ann Thorac Surg. 2007 Sep;84(3):1019-21.

5. Scolapio JS, Deluise W, Al-Haddad M, Bianchi L, Cesario K. Continued medical education provided by medical journals: the "red journal's" experience.Am J Gastroenterol. 2007 Aug;102(8):1590-3.

6. Al-Haddad M, Raimondo M. Management of acute pancreatitis in view of the published guidelines: are we compliant enough?Dig Liver Dis. 2007 Sep;39(9):847-8.

7. Al-Haddad M, Martin JK, Nguyen J, Pungpapong S, Raimondo M, Woodward T, Kim G, Noh K, Wallace MB. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study.J Gastrointest Surg. 2007 Sep;11(9):1168-74.

8. Al-Haddad M, Ward EM, DeVault KR, Bouras EP, Raimondo M. Vascular ectasia of the proximal stomach.Dig Dis Sci. 2007 May;52(5):1367-9.

9. Al-Haddad M, Pungpapong S, Wallace MB, Raimondo M, Woodward TA. Antegrade and retrograde endoscopic approach in the establishment of a neo-esophagus: a novel technique.Gastrointest Endosc. 2007 Feb;65(2):290-4.

10. Al-Haddad M, Raimondo M, Woodward T, Krishna M, Pungpapong S, Noh K, Wallace MB. Safety and efficacy of cytology brushings versus standard FNA in evaluating cystic lesions of the pancreas: a pilot study.Gastrointest Endosc. 2007 May;65(6):894-8.

11. Al-Haddad M, Raimondo M. Upper gastrointestinal bleed from esophageal diverticula in a patient with dermatomyositis.Dig Dis Sci. 2007 Jan;52(1):137-9.

12. Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss.Dig Dis Sci. 2007 Jan;52(1):105-9.

(1 OF 39)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&dopt=Abstract&db=PubMed&list_uids=18058615












13. Al-Haddad M, Ward EM, Scolapio JS, Ferguson DD, Raimondo M.

Glucagon for the relief of esophageal food impaction does it really work?Dig Dis Sci. 2006 Nov;51(11):1930-3.

14. Al-Haddad M, Wallace MB. EUS-FNA and biomarkers for the staging of non-small cell lung cancer.Endoscopy. 2006 Jun;38 Suppl 1:S114-7.

15. Al-Haddad M, Wallace MB. Molecules and markers for endosonographers: what do we need to know and measure?Endoscopy. 2006 Jun;38 Suppl 1:S50-3.

16. Al-Haddad M, Wallace MB. Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration.Cytopathology. 2006 Feb;17(1):3-9.

Mazen Alsatie

1. Alsatie M, Chalasani N, Kwo PY. Management of hepatitis C infection after liver transplantation.Drugs. 2007;67(6):871-85.

2. Alsatie M, Kwo PY, Gingerich JR, Qi R, Eckert G, Cummings OW, Imperiale TF. A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.J Clin Gastroenterol. 2007 Apr;41(4):416-21.

3. DeWitt J, Alsatie M, LeBlanc J, McHenry L, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of left adrenal gland masses.Endoscopy. 2007 Jan;39(1):65-71.

4. Shen H, Alsatie M, Eckert G, Chalasani N, Lumeng L, Kwo PY. Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.Clin Gastroenterol Hepatol. 2004 Apr;2(4):330-6.

Naga Chalasani

1. Khashab M, Chalasani N. Use of insulin sensitizers in NASH.Endocrinol Metab Clin North Am. 2007 Dec;36(4):1067-87; xi.

2. Bhardwaj SS, Chalasani N. Lipid-lowering agents that cause drug-induced hepatotoxicity.Clin Liver Dis. 2007 Aug;11(3):597-613, vii.

3. Shen H, Agarwal D, Qi R, Chalasani N, Liangpunsakul S, Lumeng L, Yoo H, Kwo P. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.Aliment Pharmacol Ther. 2007 Aug 1;26(3):393-400.


(2 OF 39)













5. Chalasani N, Saha C, Teal E.

Are there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?J Hepatol. 2007 Jul;47(1):123-7.

6. Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.Hepatology. 2007 Apr;45(4):870-8.

7. Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93.

8. Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, Bansal N, Chalasani N. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.J Clin Gastroenterol. 2007 Feb;41(2):206-10.

9. Fridell JA, Saxena R, Chalasani NP, Goggins WC, Powelson JA, Cummings OW. Complete reversal of glycogen hepatopathy with pancreas transplantation: two cases.Transplantation. 2007 Jan 15;83(1):84-6.

10. Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693.

11. Vuppalanchi R, Chalasani N, Saxena R. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.Am J Surg Pathol. 2006 Dec;30(12):1619-23.

12. Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL. Autoimmune hepatitis triggered by statins.J Clin Gastroenterol. 2006 Sep;40(8):757-61.

13. Lim JR, Faught PR, Chalasani NP, Molleston JP. Severe liver injury after initiating therapy with atomoxetine in two children.J Pediatr. 2006 Jun;148(6):831-4.

14. Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85.

15. Chalasani N, Teal E, Hall SD. Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.Am J Gastroenterol. 2005 Jun;100(6):1317-21.

16. Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.Hepatology. 2005 May;41(5):1144-50.

17. Pinto AG, Horlander J, Chalasani N, Hamman M, Asghar A, Kolwankar D, Hall SD. Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.Br J Clin Pharmacol. 2005 Apr;59(4):440-6.

18. Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver.Hepatology. 2005 Apr;41(4):690-5.

(3 OF 39)















19. Liangpunsakul S, Chalasani N.

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).Am J Med Sci. 2005 Mar;329(3):111-6.

20. Pinto AG, Wang YH, Chalasani N, Skaar T, Kolwankar D, Gorski JC, Liangpunsakul S, Hamman MA, Arefayene M, Hall SD. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.Clin Pharmacol Ther. 2005 Mar;77(3):178-88.

21. Adigun AQ, Pinto AG, Flockhart DA, Gorski JC, Li L, Hall SD, Chalasani N. Effect of cirrhosis and liver transplantation on the gender difference in QT interval.Am J Cardiol. 2005 Mar 1;95(5):691-4.

22. Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.J Clin Gastroenterol. 2005 Mar;39(3):237-42.

23. Vuppalanchi R, Teal E, Chalasani N. Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.Am J Med Sci. 2005 Feb;329(2):62-5.

24. Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M, Riely C, Martin P, Teperman L, Jiao J, Lopez-Talavera JC. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.Hepatology. 2005 Feb;41(2):289-98.

25. Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: results from the NHANES III.Kidney Int. 2005 Jan;67(1):285-90.

26. Liangpunsakul S, Chalasani N. Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III).J Clin Gastroenterol. 2004 Nov-Dec;38(10):891-7.

27. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity.Clin Liver Dis. 2004 Aug;8(3):535-47, viii.

28. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.Am J Gastroenterol. 2004 Aug;99(8):1497-502.

29. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31.

30. Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.Gastroenterology. 2004 May;126(5):1287-92.


(4 OF 39)














32. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.Liver Transpl. 2004 Mar;10(3):404-7.

33. Liangpunsakul S, Agarwal D, Horlander JC, Kieff B, Chalasani N. Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation.Transplant Proc. 2003 Dec;35(8):2995-7.

34. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?Am J Gastroenterol. 2003 Dec;98(12):2771-6.

35. Imperiale TF, Chalasani N, Klein RW. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.Am J Gastroenterol. 2003 Dec;98(12):2742-50.

36. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients.Am J Gastroenterol. 2003 Nov;98(11):2440-7.

37. Liangpunsakul S, Chalasani N. Treatment of Nonalcoholic Fatty Liver Disease.Curr Treat Options Gastroenterol. 2003 Dec;6(6):455-463.

38. Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis.Am J Med Sci. 2003 Sep;326(3):111-6.

39. Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.Am J Gastroenterol. 2003 Aug;98(8):1849-55.

40. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study.Am J Gastroenterol. 2003 Mar;98(3):653-9.

41. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.Hepatology. 2003 Mar;37(3):544-50.

Michael Chiorean

1. Maglinte DD, Sandrasegaran K, Lappas JC, Chiorean M. CT Enteroclysis.Radiology. 2007 Dec;245(3):661-71.

2. Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn's disease.Am J Gastroenterol. 2007 Nov;102(11):2541-50.

3. Maglinte DD, Sandrasegaran K, Chiorean M, Dewitt J, McHenry L, Lappas JC. Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases.AJR Am J Roentgenol. 2007 Aug;189(2):306-12.

(5 OF 39)














4. Jafri HS, Sofianos C, Hattab EM, Overhiser AJ, Chiorean M.

Temporal arteritis presenting with gastrointestinal symptoms in a middle aged man.J Gen Intern Med. 2006 Jul;21(7):C4-6.

Won Cho

1. Park JS, Choi YJ, Siegrist VJ, Ko YS, Cho WK. Permissive role of calcium on regulatory volume decrease in freshly isolated mouse cholangiocytes.Pflugers Arch. 2007 Nov;455(2):261-71.

2. Chen B, Nicol G, Cho WK. Role of calcium in volume-activated chloride currents in a mouse cholangiocyte cell line.J Membr Biol. 2007 Jan;215(1):1-13.

3. Chen SC, Cummings OW, Hartley MP, Filomena CA, Cho WK. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.Dig Dis Sci. 2006 May;51(5):952-5.

4. Raikwar NS, Cho WK, Bowen RF, Deeg MA. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E463-70.

5. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver.Gastroenterology. 2004 Dec;127(6):1798-808.

6. Chen B, Nicol G, Cho WK. Electrophysiological characterization of volume-activated chloride currents in mouse cholangiocyte cell line.Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1158-67.

7. Cho WK, Siegrist VJ, Zinzow W. Impaired regulatory volume decrease in freshly isolated cholangiocytes from cystic fibrosis mice: implications for cystic fibrosis transmembrane conductance regulator effect on potassium conductance.J Biol Chem. 2004 Apr 9;279(15):14610-8.

8. Pinaire J, Chou WY, Morton M, You M, Zeng Y, Cho WK, Galli A, Everett L, Breen H, Dumaual N, Smith JR, Crabb D. Identification of a retinoid receptor response element in the human aldehyde dehydrogenase-2 promoter.Alcohol Clin Exp Res. 2003 Dec;27(12):1860-6.

9. Beniwal RS, Cummings OW, Cho WK. Symptomatic gastrointestinal sarcoidosis: case report and review of the literature.Dig Dis Sci. 2003 Jan;48(1):174-8.

David W. Crabb

1. Fischer M, Wetherill LF, Carr LG, You M, Crabb DW. Association of the aldehyde dehydrogenase 2 promoter polymorphism with alcohol consumption and reactions in an American Jewish population.Alcohol Clin Exp Res. 2007 Oct;31(10):1654-9.

2. Crabb DW, Liangpunsakul S. Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes.Novartis Found Symp. 2007;285:4-16; discussion 16-22, 198-9.

(6 OF 39)













3. Bell RL, Kimpel MW, Rodd ZA, Strother WN, Bai F, Peper CL, Mayfield RD, Lumeng L, Crabb DW, McBride WJ, Witzmann FA.

Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol.Alcohol. 2006 Aug;40(1):3-17.

4. Crabb DW. Alcohol Deranges Hepatic Lipid Metabolism via Altered Transcriptional Regulation.Trans Am Clin Climatol Assoc. 2004;115:273-87.

5. Lumeng L, Crabb DW. Alcoholic liver disease.Curr Opin Gastroenterol. 2001 May;17(3):211-20.


7. Crabb DW, Liangpunsakul S. Alcohol and lipid metabolism.J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S56-60.

8. McClintick JN, Crabb DW, Tian H, Pinaire J, Smith JR, Jerome RE, Edenberg HJ. Global effects of vitamin A deficiency on gene expression in rat liver: evidence for hypoandrogenism.J Nutr Biochem. 2006 May;17(5):345-55.

9. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.Hepatology. 2005 Sep;42(3):568-77.

10. You M, Crabb DW. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins.Alcohol. 2004 Aug;34(1):39-43.

11. Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.Alcohol. 2004 Aug;34(1):35-8.

12. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver.Gastroenterology. 2004 Dec;127(6):1798-808.

13. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.Am J Gastroenterol. 2004 Aug;99(8):1497-502.

14. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G1-6.

15. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.Proc Nutr Soc. 2004 Feb;63(1):49-63.

(7 OF 39)














16. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV.

Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?Am J Gastroenterol. 2003 Dec;98(12):2771-6.

17. Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.Am J Gastroenterol. 2003 Aug;98(8):1849-55.

18. Witzmann FA, Li J, Strother WN, McBride WJ, Hunter L, Crabb DW, Lumeng L, Li TK. Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats.Proteomics. 2003 Jul;3(7):1335-44.

19. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.J Biol Chem. 2003 Jul 25;278(30):27997-8004.

20. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.Hepatology. 2003 Mar;37(3):544-50.

21. McClintick JN, Jerome RE, Nicholson CR, Crabb DW, Edenberg HJ. Reproducibility of oligonucleotide arrays using small samples.BMC Genomics. 2003 Jan 30;4(1):4.

John M. DeWitt

1. Lall CG, Howard TJ, Skandarajah A, DeWitt JM, Aisen AM, Sandrasegaran K. New concepts in staging and treatment of locally advanced pancreatic head cancer.AJR Am J Roentgenol. 2007 Nov;189(5):1044-50.

2. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD.Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4.

3. Attasaranya S, Pais S, LeBlanc J, McHenry L, Sherman S, DeWitt JM. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts.JOP. 2007 Sep 7;8(5):553-63.

4. Kesler KA, Helft PR, Werner EA, Jain NP, Brooks JA, DeWitt JM, Leblanc JK, Fineberg NS, Einhorn LH, Brown JW. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.Ann Thorac Surg. 2005 Apr;79(4):1116-21.

5. Kahi CJ, Dewitt JM, Lykens M, LeBlanc JK, Chappo J, McHenry L, Sherman S. Diagnosis of a malignant mesothelioma by EUS-guided FNA of a mediastinal lymph node.Gastrointest Endosc. 2004 Nov;60(5):859-61.

6. LeBlanc JK, Devereaux BM, Imperiale TF, Kesler K, DeWitt JM, Cummings O, Ciaccia D, Sherman S, Mathur P, Conces D, Brooks J, Chriswell M, Einhorn L, Collins E.Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography.Am J Respir Crit Care Med. 2005 Jan 15;171(2):177-82.

(8 OF 39)















7. Lim JR, Fitzgerald JF, Dewitt JM.

Duodenal duplication cysts.J Pediatr Gastroenterol Nutr. 2004 Jan;38(1):26, 47.

8. DeWitt JM, Chappo J, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of melanoma metastatic to the pancreas: report of two cases and review.Endoscopy. 2003 Mar;35(3):219-22.

Hala Fatima

1. Fatima H, Rex DK, Rothstein R, Rahmani E, Nehme O, Dewitt J, Helper D, Toor A, Bensen S. Cecal insertion and withdrawal times with wide-angle versus standard colonoscopes: a randomized controlled trial.Clin Gastroenterol Hepatol. 2008 Jan;6(1):109-14.

2. Fatima H, Gregory A, Matthews D. Colocolonic intussusception secondary to an intraluminal lipoma.Clin Gastroenterol Hepatol. 2007 Sep;5(9):e38.

3. Fatima H, Rex DK. Minimizing endoscopic complications: colonoscopic polypectomy.Gastrointest Endosc Clin N Am. 2007 Jan;17(1):145-56, viii.

Evan L. Fogel

1. Attasaranya S, Cheon YK, Vittal H, Howell DA, Wakelin DE, Cunningham JT, Ajmere N, Ste Marie RW Jr, Bhattacharya K, Gupta K, Freeman ML, Sherman S, McHenry L, Watkins JL, Fogel EL, Schmidt S, Lehman GA.Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series.Gastrointest Endosc. 2008 Jan 4;.

2. Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, Schmidt S, Lazzell-Pannell L, Lehman GA. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.Gastrointest Endosc. 2007 Dec;66(6):1126-32.

3. Saad AM, Fogel EL, McHenry L, Watkins JL, Sherman S, Lazzell-Pannell L, Lehman GA. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.Gastrointest Endosc. 2007 Oct 26;.

4. Yimcharoen P, Fogel EL, McHenry L, Watkins J, Sherman S, Lehman GA. [State-art: diagnosis and management in pancreas divisum]Rev Gastroenterol Mex. 2005 Jul;70 Suppl 1:133-40.

5. Alazmi WM, Mosler P, Watkins JL, McHenry L, Fogel EL, Sherman S, Lehman GA. Predicting pancreas divisum by inspection of the minor papilla: a prospective study.J Clin Gastroenterol. 2007 Apr;41(4):422-6.

6. Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, Lehman GA. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.Gastrointest Endosc. 2007 Mar;65(3):385-93.

7. Alazmi WM, Fogel EL, Watkins JL, McHenry L, Sherman S, Lehman GA. The effect of biliary sphincterotomy on serum cholesterol level in postcholecystectomy patients: a pilot study.Can J Gastroenterol. 2007 Feb;21(2):81-4.

(9 OF 39)














8. Khan MH, Howard TJ, Fogel EL, Sherman S, McHenry L, Watkins JL, Canal DF, Lehman GA.

Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center.Gastrointest Endosc. 2007 Feb;65(2):247-52.

9. Fogel EL, Toth TG, Lehman GA, DiMagno MJ, DiMagno EP. Does endoscopic therapy favorably affect the outcome of patients who have recurrent acute pancreatitis and pancreas divisum?Pancreas. 2007 Jan;34(1):21-45.

10. Cheon YK, Fogel EL. ERCP topics.Endoscopy. 2006 Nov;38(11):1092-7.

11. Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA. Chemotherapy-induced sclerosing cholangitis.Clin Radiol. 2006 Aug;61(8):670-8.

12. Alazmi WM, Fogel EL, Watkins JL, McHenry L, Tector JA, Fridell J, Mosler P, Sherman S, Lehman GA. Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation.Endoscopy. 2006 Jun;38(6):571-4.

13. Yimcharoen P, Fogel EL, Kovacs RJ, Rosenfeld SH, McHenry L, Watkins JL, Alazmi WM, Sherman S, Lehman GA. Droperidol, when used for sedation during ERCP, may prolong the QT interval.Gastrointest Endosc. 2006 Jun;63(7):979-85.

14. Mosler P, Fogel EL. Massive Subcutaneous Emphysema after Attempted Endoscopic Retrograde Cholangiopancreatography in a Patient with a History of Bariatric Gastric Bypass Surgery.Endoscopy. 2006 Apr 27;.

15. Alazmi WM, McHenry L, Watkins JL, Fogel EL, Schmidt S, Sherman S, Lehman GL. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.J Clin Gastroenterol. 2006 Apr;40(4):353-7.

16. Alazmi WM, Fogel EL, Schmidt S, Watkins JL, McHenry L, Sherman S, Lehman GA. ERCP findings in idiopathic pancreatitis: patients who are cystic fibrosis gene positive and negative.Gastrointest Endosc. 2006 Feb;63(2):234-9.

17. Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA.Risk factors for post-ERCP pancreatitis: a prospective multicenter study.Am J Gastroenterol. 2006 Jan;101(1):139-47.

18. Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, Schmidt S, Lazzell-Pannell L, Sherman S, Lehman GA. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study.Gastrointest Endosc. 2006 Jan;63(1):71-7.

19. Cheng CL, Fogel EL, Sherman S, McHenry L, Watkins JL, Croffie JM, Gupta SK, Fitzgerald JF, Lazzell-Pannell L, Schmidt S, Lehman GA.Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report.J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):445-53.

20. Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA.

(10 OF 39)

















Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.Gastrointest Endosc. 2005 Aug;62(2):245-50.

21. Fogel EL, Sherman S. Abdominal pain with fluctuating elevation of amylase and AST.Clin Gastroenterol Hepatol. 2005 Jun;3(6):538-42.

22. Fogel EL, McHenry L, Sherman S, Watkins JL, Lehman GA. Therapeutic biliary endoscopy.Endoscopy. 2005 Feb;37(2):139-45.

23. Cheng CL, Sherman S, Fogel EL, McHenry L, Watkins JL, Fukushima T, Howard TJ, Lazzell-Pannell L, Lehman GA. Endoscopic snare papillectomy for tumors of the duodenal papillae.Gastrointest Endosc. 2004 Nov;60(5):757-64.

24. Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, Lehman GA. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.Clin Gastroenterol Hepatol. 2004 Apr;2(4):322-9.

25. Fogel EL. Endoscopic retrograde cholangiopancreatography topics.Endoscopy. 2003 Nov;35(11):913-9.

26. Fogel EL, Sherman S, Bucksot L, Shelly L, Lehman GA. Effects of droperidol on the pancreatic and biliary sphincters.Gastrointest Endosc. 2003 Oct;58(4):488-92.

27. de Bellis M, Fogel EL, Sherman S, Watkins JL, Chappo J, Younger C, Cramer H, Lehman GA. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction.Gastrointest Endosc. 2003 Aug;58(2):176-82.

28. Fogel EL, Sherman S. Acute biliary pancreatitis: when should the endoscopist intervene?Gastroenterology. 2003 Jul;125(1):229-35.

29. Sherman S, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Earle D, Temkit M, Lehman GA.Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.Gastrointest Endosc. 2003 Jul;58(1):23-9.

30. Devereaux BM, Fogel EL, Bucksot L, Shelly LA, Lehman GA, Sherman S. Clinical utility of stent cytology for the diagnosis of pancreaticobiliary neoplasms.Am J Gastroenterol. 2003 May;98(5):1028-31.

31. Devereaux BM, Fein S, Purich E, Trout JR, Lehman GA, Fogel EL, Phillips S, Etemad R, Jowell P, Toskes PP, Sherman S. A new synthetic porcine secretin for facilitation of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a multicenter, randomized, double-blind comparative study.Gastrointest Endosc. 2003 May;57(6):643-7.

32. Park SH, Watkins JL, Fogel EL, Sherman S, Lazzell L, Bucksot L, Lehman GA. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.Gastrointest Endosc. 2003 Apr;57(4):483-91.

(11 OF 39)














33. Park SH, de Bellis M, McHenry L, Fogel EL, Lazzell L, Bucksot L, Sherman S, Lehman GA.

Use of methylene blue to identify the minor papilla or its orifice in patients with pancreas divisum.Gastrointest Endosc. 2003 Mar;57(3):358-63.

34. Fogel EL, Sherman S, Park SH, McHenry L, Lehman GA. Therapeutic biliary endoscopy.Endoscopy. 2003 Feb;35(2):156-63.

Debra J. Helper

1. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.Gastroenterology. 2003 Dec;125(6):1670-7.

2. Rex DK, Chadalawada V, Helper DJ. Wide angle colonoscopy with a prototype instrument: impact on miss rates and efficiency as determined by back-to-back colonoscopies.Am J Gastroenterol. 2003 Sep;98(9):2000-5.

3. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps.J Clin Gastroenterol. 2003 May-Jun;36(5):399-402.

Thomas F. Imperiale

1. Kahi CJ, Azzouz F, Juliar BE, Imperiale TF. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance.Gastrointest Endosc. 2007 Sep;66(3):544-50.

2. Imperiale TF, Dominitz JA, Provenzale DT, Boes LP, Rose CM, Bowers JC, Musick BS, Azzouz F, Perkins SM. Predicting poor outcome from acute upper gastrointestinal hemorrhage.Arch Intern Med. 2007 Jun 25;167(12):1291-6.


4. Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.Hepatology. 2007 Apr;45(4):870-8.

5. Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.Clin Gastroenterol Hepatol. 2006 Jun;4(6):717-25; quiz 664.

6. Kahi CJ, Jensen DM, Sung JJ, Bleau BL, Jung HK, Eckert G, Imperiale TF. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.Gastroenterology. 2005 Sep;129(3):855-62.

7. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.N Engl J Med. 2004 Dec 23;351(26):2704-14.

(12 OF 39)













8. Kahi CJ, Imperiale TF.

Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.Am J Med. 2004 Dec 1;117(11):837-41.

9. DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, Ciaccia D, Lane KA, Maglinte D, Kopecky K, LeBlanc J, McHenry L, Madura J, Aisen A, Cramer H, Cummings O, Sherman S.Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.Ann Intern Med. 2004 Nov 16;141(10):753-63.


11. Kieff BJ, Eckert GJ, Imperiale TF. Is diverticulosis associated with colorectal neoplasia? A cross-sectional colonoscopic study.Am J Gastroenterol. 2004 Oct;99(10):2007-11.

12. Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA. Risk of pancreatitis with mutation of the cystic fibrosis gene.Am J Gastroenterol. 2004 Jul;99(7):1358-63.

13. Imperiale TF, Chalasani N, Klein RW. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.Am J Gastroenterol. 2003 Dec;98(12):2742-50.

14. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.Ann Intern Med. 2003 Dec 16;139(12):959-65.

15. Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, Ahmad UA. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea.Dig Dis Sci. 2003 Oct;48(10):2077-82.

16. Imperiale TF. Aspirin and the prevention of colorectal cancer.N Engl J Med. 2003 Mar 6;348(10):879-80.

17. Dave S, Hui S, Kroenke K, Imperiale TF. Is the distal hyperplastic polyp a marker for proximal neoplasia?J Gen Intern Med. 2003 Feb;18(2):128-37.

Charles J. Kahi

1. Kahi CJ, Saxena R, Temkit M, Canlas K, Roberts S, Knox K, Wilkes D, Kwo PY. Hepatobiliary disease in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):117-23.

2. Kahi CJ, Rex DK. Primer: Applying the new postpolypectomy surveillance guidelines in clinical practice.Nat Clin Pract Gastroenterol Hepatol. 2007 Oct;4(10):571-8.

(13 OF 39)















3. Berkram P, Bedano PM, Kahi CJ, Illamperuma C, Matthews DE, Antony AC.

A landlubber with an ancient mariner's leaky vessels.Gastrointest Endosc. 2007 Nov;66(5):1065-6.

4. Kahi CJ, Azzouz F, Juliar BE, Imperiale TF. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance.Gastrointest Endosc. 2007 Sep;66(3):544-50.

5. Vuppalanchi R, Vakili ST, Kahi CJ. Isolated melanosis of the gastric antrum: an unusual endoscopic finding.Clin Gastroenterol Hepatol. 2007 Jan;5(1):e2.

6. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O'Brien MJ, Simmang C, Thorson AG, Winawer SJ.Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer.CA Cancer J Clin. 2006 May-Jun;56(3):160-7; quiz 185-6.

7. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O'Brien MJ, Simmang C, Thorson AG, Winawer SJ.Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2006 May;130(6):1865-71.

8. Kahi CJ, Jensen DM, Sung JJ, Bleau BL, Jung HK, Eckert G, Imperiale TF. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.Gastroenterology. 2005 Sep;129(3):855-62.

9. Kahi CJ, Rex DK. Screening and surveillance of colorectal cancer.Gastrointest Endosc Clin N Am. 2005 Jul;15(3):533-47, ix.

10. Kahi CJ, Wheat LJ, Allen SD, Sarosi GA. Gastrointestinal histoplasmosis.Am J Gastroenterol. 2005 Jan;100(1):220-31.

11. Kahi CJ, Imperiale TF. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.Am J Med. 2004 Dec 1;117(11):837-41.


13. Kahi CJ, Rex DK. Current and future trends in colorectal cancer screening.Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):137-44.

14. Kahi CJ, Rex DK. Bowel obstruction and pseudo-obstruction.Gastroenterol Clin North Am. 2003 Dec;32(4):1229-47.

15. Dewitt J, Ghorai S, Kahi C, Leblanc J, McHenry L, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S. EUS-FNA of recurrent postoperative extraluminal and metastatic malignancy.Gastrointest Endosc. 2003 Oct;58(4):542-8.

(14 OF 39)
















16. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J.

Improved patient survival after acute variceal bleeding: a multicenter, cohort study.Am J Gastroenterol. 2003 Mar;98(3):653-9.

William Kessler

1. Kessler WR, Rex DK. Impact of bending section length on insertion and retroflexion properties of pediatric and adult colonoscopes.Am J Gastroenterol. 2005 Jun;100(6):1290-5.


3. Kessler WR, Nehme OS. Endoscopic colorectal cancer screening: screening modality versus screening interval.Am J Gastroenterol. 2003 Dec;98(12):2796-7.

Paul Y. Kwo

1. Kwo PY, Saxena R, Cummings OW, Tector AJ. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.Liver Transpl. 2007 Dec;13(12):1710-3.

2. Kahi CJ, Saxena R, Temkit M, Canlas K, Roberts S, Knox K, Wilkes D, Kwo PY. Hepatobiliary disease in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):117-23.


4. Khan M, Tector AJ, Kwo PY. Tacrolimus or microemulsified ciclosporin for immunosuppression after liver transplantation?Nat Clin Pract Gastroenterol Hepatol. 2007 Aug;4(8):424-5.



7. Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure.Curr Gastroenterol Rep. 2007 Mar;9(1):66-73.

8. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, Sanders C, Kwo PY. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival.Ann Surg. 2006 Sep;244(3):439-50.

(15 OF 39)













9. Fridell JA, Vianna R, Kwo PY, Howenstine M, Sannuti A, Molleston JP, Pescovitz MD, Tector AJ.

Simultaneous liver and pancreas transplantation in patients with cystic fibrosis.Transplant Proc. 2005 Oct;37(8):3567-9.

10. Stecker MS, Casciani T, Kwo PY, Lalka SG. Percutaneous stent placement as treatment of renal vein obstruction due to inferior vena caval thrombosis.Cardiovasc Intervent Radiol. 2006 Jan-Feb;29(1):147-50.

11. Roberts SD, Mirowski GW, Wilkes D, Kwo PY, Knox KS. Sarcoidosis. Part II: extrapulmonary and systemic manifestations.J Am Acad Dermatol. 2004 Oct;51(4):628-30.



14. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.Liver Transpl. 2004 Mar;10(3):404-7.

15. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?Am J Gastroenterol. 2003 Dec;98(12):2771-6.

16. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients.Am J Gastroenterol. 2003 Nov;98(11):2440-7.

Julia Kim LeBlanc

1. LeBlanc JK. Imaging and management of rectal cancer.Nat Clin Pract Gastroenterol Hepatol. 2007 Dec;4(12):665-76.

2. LeBlanc JK, DeWitt J, Sherman S. Endoscopic ultrasound: how does it aid the surgeon?Adv Surg. 2007;41:17-50.

3. Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.Clin Gastroenterol Hepatol. 2007 Apr;5(4):489-95.

4. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.Gastrointest Endosc. 2006 Sep;64(3):325-33.

5. Lim WC, Leblanc JK. Retroperitoneal bleeding after EUS-guided FNA of a pancreatic mass.Gastrointest Endosc. 2006 Mar;63(3):499-500; discussion 500.

(16 OF 39)














6. Lim WC, Leblanc JK, Dewitt J.

EUS-guided FNA of a peripancreatic lymphocele.Gastrointest Endosc. 2005 Sep;62(3):459-62.

7. Lim WC, Leblanc JK, Chappo JM, Howard TJ, Sherman S. Pancreatic mucinous adenocarcinoma with peritoneal metastases.Gastrointest Endosc. 2005 Jul;62(1):140-1.

8. Kesler KA, Helft PR, Werner EA, Jain NP, Brooks JA, DeWitt JM, Leblanc JK, Fineberg NS, Einhorn LH, Brown JW. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.Ann Thorac Surg. 2005 Apr;79(4):1116-21.



11. LeBlanc JK, Ciaccia D, Al-Assi MT, McGrath K, Imperiale T, Tao LC, Vallery S, DeWitt J, Sherman S, Collins E. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis.Gastrointest Endosc. 2004 Apr;59(4):475-81.

12. Devereaux BM, LeBlanc JK, Kesler K, Brooks J, Lehman GA, Sherman S, Ciaccia D. Giant fibrovascular polyp of the esophagus.Endoscopy. 2003 Nov;35(11):970-2.

13. LeBlanc JK, Espada R, Ergun G. Non-small cell lung cancer staging techniques and endoscopic ultrasound: tissue is still the issue.Chest. 2003 May;123(5):1718-25.

Glen A. Lehman



3. Attasaranya S, Abdel Aziz AM, Lehman GA. Endoscopic management of acute and chronic pancreatitis.Surg Clin North Am. 2007 Dec;87(6):1379-402.


(17 OF 39)















5. Abdel Aziz AM, Lehman GA.

Current treatment options for chronic pancreatitis.Curr Treat Options Gastroenterol. 2007 Oct;10(5):355-68.

6. Abdel Aziz AM, Lehman GA. Pancreatitis after endoscopic retrograde cholangio-pancreatography.World J Gastroenterol. 2007 May 21;13(19):2655-68.





11. Khan MH, Howard TJ, Fogel EL, Sherman S, McHenry L, Watkins JL, Canal DF, Lehman GA. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center.Gastrointest Endosc. 2007 Feb;65(2):247-52.

12. Fogel EL, Toth TG, Lehman GA, DiMagno MJ, DiMagno EP. Does endoscopic therapy favorably affect the outcome of patients who have recurrent acute pancreatitis and pancreas divisum?Pancreas. 2007 Jan;34(1):21-45.




16. Akisik MF, Sandrasegaran K, Aisen AA, Maglinte DD, Sherman S, Lehman GA. Dynamic secretin-enhanced MR cholangiopancreatography.Radiographics. 2006 May-Jun;26(3):665-77.


(18 OF 39)














18. Cheon YK, Lehman GA.

Identification of risk factors for stone recurrence after endoscopic treatment of bile duct stones.Eur J Gastroenterol Hepatol. 2006 May;18(5):461-4.





23. Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA.Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.Gastrointest Endosc. 2005 Aug;62(2):245-50.

24. Madura JA, Madura JA 2nd, Sherman S, Lehman GA. Surgical sphincteroplasty in 446 patients.Arch Surg. 2005 May;140(5):504-11; discussion 511-3.





29. Madura JA, Yum MN, Lehman GA, Sherman S, Schmidt CM. Mucin secreting cystic lesions of the pancreas: treatment by enucleation.Am Surg. 2004 Feb;70(2):106-12; discussion 113.

30. Kesler KA, Tarvin SE, Brooks JA, Rieger KM, Lehman GA, Brown JW. Thoracoscopy-assisted Heller myotomy for the treatment of achalasia: results of a minimally invasive technique.Ann Thorac Surg. 2004 Feb;77(2):385-91; discussion 391-2.

(19 OF 39)

















31. Devereaux BM, LeBlanc JK, Kesler K, Brooks J, Lehman GA, Sherman S, Ciaccia D.

Giant fibrovascular polyp of the esophagus.Endoscopy. 2003 Nov;35(11):970-2.


33. Lehman GA. Injectable and bulk-forming agents for enhancing the lower esophageal sphincter.Am J Med. 2003 Aug 18;115 Suppl 3A:188S-191S.

34. Tann M, Maglinte D, Howard TJ, Sherman S, Fogel E, Madura JA, Lehman GA. Disconnected pancreatic duct syndrome: imaging findings and therapeutic implications in 26 surgically corrected patients.J Comput Assist Tomogr. 2003 Jul-Aug;27(4):577-82.



37. Lehman GA. Acute recurrent pancreatitis.Can J Gastroenterol. 2003 Jun;17(6):381-3.

38. Devereaux BM, Fogel EL, Bucksot L, Shelly LA, Lehman GA, Sherman S. Clinical utility of stent cytology for the diagnosis of pancreaticobiliary neoplasms.Am J Gastroenterol. 2003 May;98(5):1028-31.

39. Madura JA, Canal DF, Lehman GA. Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis.Arch Surg. 2003 Jun;138(6):644-9; discussion 649-50.

40. Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA.Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.Arch Surg. 2003 Jun;138(6):610-7; discussion 617-8.

41. Lehman GA. The history and future of implantation therapy for gastroesophageal reflux disease.Gastrointest Endosc Clin N Am. 2003 Jan;13(1):157-65, xi.

42. Devereaux BM, Fein S, Purich E, Trout JR, Lehman GA, Fogel EL, Phillips S, Etemad R, Jowell P, Toskes PP, Sherman S. A new synthetic porcine secretin for facilitation of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a multicenter, randomized, double-blind comparative study.Gastrointest Endosc. 2003 May;57(6):643-7.

43. Park SH, Watkins JL, Fogel EL, Sherman S, Lazzell L, Bucksot L, Lehman GA. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter

(20 OF 39)
















of Oddi dysfunction and normal pancreatogram.Gastrointest Endosc. 2003 Apr;57(4):483-91.

44. Park SH, de Bellis M, McHenry L, Fogel EL, Lazzell L, Bucksot L, Sherman S, Lehman GA. Use of methylene blue to identify the minor papilla or its orifice in patients with pancreas divisum.Gastrointest Endosc. 2003 Mar;57(3):358-63.


Suthat Liangpunsakul


2. Crabb DW, Liangpunsakul S. Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes.Novartis Found Symp. 2007;285:4-16; discussion 16-22, 198-9.


4. Crabb DW, Liangpunsakul S. Alcohol and lipid metabolism.J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S56-60.

5. Subramanian S, Liangpunsakul S, Rex DK. Preprocedure patient values regarding sedation for colonoscopy.J Clin Gastroenterol. 2005 Jul;39(6):516-9.

6. Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.Hepatology. 2005 May;41(5):1144-50.

7. Chen SC, Liangpunsakul S, Rex DK. Watermelon colon treated by argon plasma coagulation.Gastrointest Endosc. 2005 Apr;61(4):631-3.

8. Liangpunsakul S, Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).Am J Med Sci. 2005 Mar;329(3):111-6.

9. Pinto AG, Wang YH, Chalasani N, Skaar T, Kolwankar D, Gorski JC, Liangpunsakul S, Hamman MA, Arefayene M, Hall SD. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.Clin Pharmacol Ther. 2005 Mar;77(3):178-88.

(21 OF 39)












10. Liangpunsakul S, Chalasani N.

Relationship between hepatitis C and microalbuminuria: results from the NHANES III.Kidney Int. 2005 Jan;67(1):285-90.

11. Liangpunsakul S, Chalasani N. Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III).J Clin Gastroenterol. 2004 Nov-Dec;38(10):891-7.

12. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity.Clin Liver Dis. 2004 Aug;8(3):535-47, viii.

13. Liangpunsakul S, Maglinte DD, Rex DK. Comparison of wireless capsule endoscopy and conventional radiologic methods in the diagnosis of small bowel disease.Gastrointest Endosc Clin N Am. 2004 Jan;14(1):43-50.

14. Ulmer BJ, Hansen JJ, Overley CA, Symms MR, Chadalawada V, Liangpunsakul S, Strahl E, Mendel AM, Rex DK. Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists.Clin Gastroenterol Hepatol. 2003 Nov;1(6):425-32.


16. Liangpunsakul S, Agarwal D, Horlander JC, Kieff B, Chalasani N. Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation.Transplant Proc. 2003 Dec;35(8):2995-7.

17. Liangpunsakul S, Mays L, Rex DK. Performance of Given suspected blood indicator.Am J Gastroenterol. 2003 Dec;98(12):2676-8.

18. Liangpunsakul S, Chalasani N. Treatment of Nonalcoholic Fatty Liver Disease.Curr Treat Options Gastroenterol. 2003 Dec;6(6):455-463.

19. Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis.Am J Med Sci. 2003 Sep;326(3):111-6.

20. Liangpunsakul S, Chadalawada V, Rex DK, Maglinte D, Lappas J. Wireless capsule endoscopy detects small bowel ulcers in patients with normal results from state of the art enteroclysis.Am J Gastroenterol. 2003 Jun;98(6):1295-8.

Lawrence Lumeng


(22 OF 39)













2. Bell RL, Kimpel MW, Rodd ZA, Strother WN, Bai F, Peper CL, Mayfield RD, Lumeng L, Crabb DW, McBride WJ, Witzmann FA.

Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol.Alcohol. 2006 Aug;40(1):3-17.

3. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E, Jerome RE, Lumeng L, Nurnberger JI Jr, Edenberg HJ, McBride WJ, Niculescu AB.Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach.Pharmacogenomics J. 2007 Aug;7(4):222-56.



6. Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ. The alcohol-preferring P rat and animal models of excessive alcohol drinking.Addict Biol. 2006 Sep;11(3-4):270-88.

7. Oster SM, Toalston JE, Kuc KA, Pommer TJ, Murphy JM, Lumeng L, Bell RL, McBride WJ, Rodd ZA. Effects of multiple alcohol deprivations on operant ethanol self-administration by high-alcohol-drinking replicate rat lines.Alcohol. 2006 Apr;38(3):155-64.

8. Engleman EA, Ingraham CM, McBride WJ, Lumeng L, Murphy JM. Extracellular dopamine levels are lower in the medial prefrontal cortex of alcohol-preferring rats compared to Wistar rats.Alcohol. 2006 Jan;38(1):5-12.

9. Bice PJ, Foroud T, Carr LG, Zhang L, Liu L, Grahame NJ, Lumeng L, Li TK, Belknap JK. Identification of QTLs influencing alcohol preference in the High Alcohol Preferring (HAP) and Low Alcohol Preferring (LAP) mouse lines.Behav Genet. 2006 Mar;36(2):248-60.

10. Carr LG, Habegger K, Spence JP, Liu L, Lumeng L, Foroud T. Development of congenic rat strains for alcohol consumption derived from the alcohol-preferring and nonpreferring rats.Behav Genet. 2006 Mar;36(2):285-90.

11. Bell RL, Rodd ZA, Sable HJ, Schultz JA, Hsu CC, Lumeng L, Murphy JM, McBride WJ. Daily patterns of ethanol drinking in peri-adolescent and adult alcohol-preferring (P) rats.Pharmacol Biochem Behav. 2006 Jan;83(1):35-46.

12. Alam I, Robling AG, Weissing S, Carr LG, Lumeng L, Turner CH. Bone mass and strength: phenotypic and genetic relationship to alcohol preference in P/NP and HAD/LAD rats.Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76.

13. Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ. Prolonged increase in the sensitivity of the posterior ventral tegmental area to the reinforcing effects of ethanol following repeated exposure to cycles of ethanol access and deprivation.J Pharmacol Exp Ther. 2005 Nov;315(2):648-57.

14. Sable HJ, Rodd ZA, Bell RL, Schultz JA, Lumeng L, McBride WJ. Effects of ethanol drinking on central nervous system functional activity of alcohol-preferring rats.Alcohol. 2005 Feb;35(2):129-35.

(23 OF 39)















15. Strother WN, McBride WJ, Lumeng L, Li TK.

Effects of acute administration of ethanol on cerebral glucose utilization in adult alcohol-preferring and alcohol-nonpreferring rats.Alcohol. 2005 Feb;35(2):119-28.

16. Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ. Chronic ethanol drinking by alcohol-preferring rats increases the sensitivity of the posterior ventral tegmental area to the reinforcing effects of ethanol.Alcohol Clin Exp Res. 2005 Mar;29(3):358-66.

17. Edenberg HJ, Strother WN, McClintick JN, Tian H, Stephens M, Jerome RE, Lumeng L, Li TK, McBride WJ. Gene expression in the hippocampus of inbred alcohol-preferring and -nonpreferring rats.Genes Brain Behav. 2005 Feb;4(1):20-30.

18. Bell RL, Rodd ZA, Boutwell CL, Hsu CC, Lumeng L, Murphy JM, Li TK, McBride WJ. Effects of long-term episodic access to ethanol on the expression of an alcohol deprivation effect in low alcohol-consuming rats.Alcohol Clin Exp Res. 2004 Dec;28(12):1867-74.

19. Hwang BH, Suzuki R, Lumeng L, Li TK, McBride WJ. Innate differences in neuropeptide Y (NPY) mRNA expression in discrete brain regions between alcohol-preferring (P) and -nonpreferring (NP) rats: a significantly low level of NPY mRNA in dentate gyrus of the hippocampus and absence of NPY mRNA in the medial habenular nucleus of P rats.Neuropeptides. 2004 Dec;38(6):359-68.

20. Liang T, Habegger K, Spence JP, Foroud T, Ellison JA, Lumeng L, Li TK, Carr LG. Glutathione S-transferase 8-8 expression is lower in alcohol-preferring than in alcohol-nonpreferring rats.Alcohol Clin Exp Res. 2004 Nov;28(11):1622-8.

21. Bell RL, Rodd ZA, Hsu CC, Lumeng L, Li TK, Murphy JM, McBride WJ. Effects of concurrent access to a single concentration or multiple concentrations of ethanol on ethanol intake by periadolescent high-alcohol-drinking rats.Alcohol. 2004 Jun;33(2):107-15.

22. Hwang BH, Stewart R, Zhang JK, Lumeng L, Li TK. Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference.Brain Res. 2004 Nov 5;1026(1):143-50.

23. Rodd ZA, Bell RL, Melendez RI, Kuc KA, Lumeng L, Li TK, Murphy JM, McBride WJ. Comparison of intracranial self-administration of ethanol within the posterior ventral tegmental area between alcohol-preferring and Wistar rats.Alcohol Clin Exp Res. 2004 Aug;28(8):1212-9.


25. Suzuki R, Lumeng L, McBride WJ, Li TK, Hwang BH. Reduced neuropeptide Y mRNA expression in the central nucleus of amygdala of alcohol preferring (P) rats: its potential involvement in alcohol preference and anxiety.Brain Res. 2004 Jul 16;1014(1-2):251-4.

26. Sahr AE, Thielen RJ, Lumeng L, Li TK, McBride WJ. Long-lasting alterations of the mesolimbic dopamine system after periadolescent ethanol drinking by alcohol-preferring rats.Alcohol Clin Exp Res. 2004 May;28(5):702-11.

(24 OF 39)













27. Rodd ZA, Bell RL, McKinzie DL, Webster AA, Murphy JM, Lumeng L, Li TK, McBride WJ.

Low-dose stimulatory effects of ethanol during adolescence in rat lines selectively bred for high alcohol intake.Alcohol Clin Exp Res. 2004 Apr;28(4):535-43.



30. Thielen RJ, Engleman EA, Rodd ZA, Murphy JM, Lumeng L, Li TK, McBride WJ. Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats.J Pharmacol Exp Ther. 2004 Apr;309(1):216-25.

31. Carr LG, Habegger K, Spence J, Ritchotte A, Liu L, Lumeng L, Li TK, Foroud T. Analyses of quantitative trait loci contributing to alcohol preference in HAD1/LAD1 and HAD2/LAD2 rats.Alcohol Clin Exp Res. 2003 Nov;27(11):1710-7.

32. Carr LG, Spence JP, Peter Eriksson CJ, Lumeng L, Li TK. AA and ANA rats exhibit the R100Q mutation in the GABAA receptor alpha 6 subunit.Alcohol. 2003 Aug-Oct;31(1-2):93-7.

33. Foroud T, Ritchotte A, Spence J, Liu L, Lumeng L, Li TK, Carr LG. Confirmation of alcohol preference quantitative trait loci in the replicate high alcohol drinking and low alcohol drinking rat lines.Psychiatr Genet. 2003 Sep;13(3):155-61.

34. Witzmann FA, Li J, Strother WN, McBride WJ, Hunter L, Crabb DW, Lumeng L, Li TK. Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats.Proteomics. 2003 Jul;3(7):1335-44.

35. Rodd ZA, Bell RL, Kuc KA, Murphy JM, Lumeng L, Li TK, McBride WJ. Effects of repeated alcohol deprivations on operant ethanol self-administration by alcohol-preferring (P) rats.Neuropsychopharmacology. 2003 Sep;28(9):1614-21.

36. Bell RL, Rodd-Henricks ZA, Kuc KA, Lumeng L, Li TK, Murphy JM, McBride WJ. Effects of concurrent access to a single concentration or multiple concentrations of ethanol on the intake of ethanol by male and female periadolescent alcohol-preferring (P) rats.Alcohol. 2003 Apr;29(3):137-48.

37. Bell RL, Rodd ZA, Hsu CC, Lumeng L, Murphy JM, McBride WJ. Amphetamine-modified acoustic startle responding and prepulse inhibition in adult and adolescent alcohol-preferring and -nonpreferring rats.Pharmacol Biochem Behav. 2003 Apr;75(1):163-71.

38. Liang T, Spence J, Liu L, Strother WN, Chang HW, Ellison JA, Lumeng L, Li TK, Foroud T, Carr LG. alpha-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4690-5.

(25 OF 39)













39. Learn JE, Smith DG, McBride WJ, Lumeng L, Li TK.

Ethanol effects on local cerebral glucose utilization in high-alcohol-drinking and low-alcohol-drinking rats.Alcohol. 2003 Jan;29(1):1-9.

40. Chester JA, Lumeng L, Li TK, Grahame NJ. High- and low-alcohol-preferring mice show differences in conditioned taste aversion to alcohol.Alcohol Clin Exp Res. 2003 Jan;27(1):12-8.

Lee McHenry




4. Schmidt CM, Yip-Schneider MT, Ralstin MC, Wentz S, Dewitt J, Sherman S, Howard TJ, McHenry L, Dutkevitch S, Goggins M, Nakeeb A, Lillemoe KD.PGE(2) in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia.J Gastrointest Surg. 2007 Nov 20;.


6. Maglinte DD, Sandrasegaran K, Chiorean M, Dewitt J, McHenry L, Lappas JC. Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases.AJR Am J Roentgenol. 2007 Aug;189(2):306-12.

7. Tann M, Sandrasegaran K, Jennings SG, Skandarajah A, McHenry L, Schmidt CM. Positron-emission tomography and computed tomography of cystic pancreatic masses.Clin Radiol. 2007 Aug;62(8):745-51.



10. DeWitt J, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of ascites.Clin Gastroenterol Hepatol. 2007 May;5(5):609-15.

(26 OF 39)















11. Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, Lehman GA.

Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.Gastrointest Endosc. 2007 Mar;65(3):385-93.









20. McHenry L, Lehman G. Difficult bile duct stones.Curr Treat Options Gastroenterol. 2006 Apr;9(2):123-32.




(27 OF 39)















24. DeWitt J, McGreevy K, LeBlanc J, McHenry L, Cummings O, Sherman S.

EUS-guided Trucut biopsy of suspected nonfocal chronic pancreatitis.Gastrointest Endosc. 2005 Jul;62(1):76-84.

25. DeWitt J, Jowell P, Leblanc J, McHenry L, McGreevy K, Cramer H, Volmar K, Sherman S, Gress F. EUS-guided FNA of pancreatic metastases: a multicenter experience.Gastrointest Endosc. 2005 May;61(6):689-96.

26. DeWitt J, Kesler K, Brooks JA, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.Dis Esophagus. 2005;18(1):21-7.





31. LeBlanc J, Youssef W, DeWitt J, Sherman S, Chappo J, McHenry L. Metastatic breast cancer to the gastroesophageal junction 14 years after radical mastectomy.Gastrointest Endosc. 2004 May;59(6):733-6.


33. Dewitt J, Youssef W, Leblanc J, McHenry L, McGreevy K, Chappo J, Cramer H, Sherman S. EUS-guided FNA of a thyroid mass.Gastrointest Endosc. 2004 Feb;59(2):307-10.

34. Dewitt J, McHenry L, Fogel E, Leblanc J, McGreevy K, Sherman S. EUS-guided methylene blue pancreatography for minor papilla localization after unsuccessful ERCP.Gastrointest Endosc. 2004 Jan;59(1):133-6.

35. Howard TJ, Villanustre N, Moore SA, DeWitt J, LeBlanc J, Maglinte D, McHenry L. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.J Gastrointest Surg. 2003 Dec;7(8):1089-95.

36. Rashdan A, Fogel E, McHenry L Jr, Lehman G, Sherman S. Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction.Gastrointest Endosc. 2003 Dec;58(6):875-8.

(28 OF 39)















37. Dewitt J, Ghorai S, Kahi C, Leblanc J, McHenry L, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S.

EUS-FNA of recurrent postoperative extraluminal and metastatic malignancy.Gastrointest Endosc. 2003 Oct;58(4):542-8.

38. DeWitt J, LeBlanc J, McHenry L, Ciaccia D, Imperiale T, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience.Am J Gastroenterol. 2003 Sep;98(9):1976-81.

39. Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA.Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.Arch Surg. 2003 Jun;138(6):610-7; discussion 617-8.

40. Park SH, de Bellis M, McHenry L, Fogel EL, Lazzell L, Bucksot L, Sherman S, Lehman GA. Use of methylene blue to identify the minor papilla or its orifice in patients with pancreas divisum.Gastrointest Endosc. 2003 Mar;57(3):358-63.


Vijay L Misra


Douglas K. Rex

1. Fatima H, Rex DK, Rothstein R, Rahmani E, Nehme O, Dewitt J, Helper D, Toor A, Bensen S. Cecal insertion and withdrawal times with wide-angle versus standard colonoscopes: a randomized controlled trial.Clin Gastroenterol Hepatol. 2008 Jan;6(1):109-14.

2. Saad A, Rex DK. Colonoscopy-induced Splenic Injury: Report of 3 Cases and Literature Review.Dig Dis Sci. 2007 Oct 13;.

3. Kahi CJ, Rex DK. Primer: Applying the new postpolypectomy surveillance guidelines in clinical practice.Nat Clin Pract Gastroenterol Hepatol. 2007 Oct;4(10):571-8.

4. Rex DK. Dosing considerations in the use of sodium phosphate bowel preparations for colonoscopy.Ann Pharmacother. 2007 Sep;41(9):1466-75.

5. Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging.Gastroenterology. 2007 Jul;133(1):42-7.

6. Overhiser AJ, Rex DK. Work and resources needed for endoscopic resection of large sessile colorectal polyps.Clin Gastroenterol Hepatol. 2007 Sep;5(9):1076-9.

(29 OF 39)














7. Rex DK, Chen SC, Overhiser AJ.

Colonoscopy technique in consecutive patients referred for prior incomplete colonoscopy.Clin Gastroenterol Hepatol. 2007 Jul;5(7):879-83.

8. Fatima H, Rex DK. Minimizing endoscopic complications: colonoscopic polypectomy.Gastrointest Endosc Clin N Am. 2007 Jan;17(1):145-56, viii.

9. Rex DK. Maximizing detection of adenomas and cancers during colonoscopy.Am J Gastroenterol. 2006 Dec;101(12):2866-77.

10. Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy.Am J Gastroenterol. 2007 Apr;102(4):856-61.

11. VanNatta ME, Rex DK. Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy.Am J Gastroenterol. 2006 Oct;101(10):2209-17.

12. Rex DK, Schwartz H, Goldstein M, Popp J, Katz S, Barish C, Karlstadt RG, Rose M, Walker K, Lottes S, Ettinger N, Zhang B. Safety and colon-cleansing efficacy of a new residue-free formulation of sodium phosphate tablets.Am J Gastroenterol. 2006 Nov;101(11):2594-604.

13. Drake LM, Chen SC, Rex DK. Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial.Am J Gastroenterol. 2006 Sep;101(9):2003-7.

14. Rex DK. Advances in colonoscopic imaging.Rev Gastroenterol Disord. 2006;6 Suppl 1:S28-32.

15. Rex DK. Overuse of postpolypectomy surveillance colonoscopy.Rev Gastroenterol Disord. 2006 Summer;6(3):198-200.

16. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy.Curr Opin Gastroenterol. 2006 Sep;22(5):536-40.

17. Rex DK, Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography.Am J Gastroenterol. 2006 Jul;101(7):1410-3.

18. Overhiser AJ, Rex DK. A patient has a 3-centimeter cecal polyp on chronic anticoagulation for a mechanical mitral valve prosthesis.Clin Gastroenterol Hepatol. 2006 Aug;4(8):972-5.

19. Rex DK. Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists.Aliment Pharmacol Ther. 2006 Jul 15;24(2):163-71.

20. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O'Brien MJ, Simmang C, Thorson AG, Winawer SJ.

(30 OF 39)
















Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer.CA Cancer J Clin. 2006 May-Jun;56(3):160-7; quiz 185-6.

21. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O'Brien MJ, Simmang C, Thorson AG, Winawer SJ.Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2006 May;130(6):1865-71.

22. Rex DK. Check my nodes please--all of them.Rev Gastroenterol Disord. 2003 Summer;3(3):181-2.

23. Rex DK, Khashab M. Colonoscopic polypectomy in retroflexion.Gastrointest Endosc. 2006 Jan;63(1):144-8.

24. Rex DK. Update on CT colonography (virtual colonoscopy) trials.Rev Gastroenterol Disord. 2005 Fall;5(4):227-9.

25. Rex DK, Heuss LT, Walker JA, Qi R. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.Gastroenterology. 2005 Nov;129(5):1384-91.

26. Rex DK, Khalfan HK. Sedation and the technical performance of colonoscopy.Gastrointest Endosc Clin N Am. 2005 Oct;15(4):661-72.

27. Rex DK. PRO: Patients with polyps smaller than 1 cm on computed tomographic colonography should be offered colonoscopy and polypectomy.Am J Gastroenterol. 2005 Sep;100(9):1903-5; discussion 1907-8.

28. Rex DK. Colonoscopic polypectomy.Rev Gastroenterol Disord. 2005 Summer;5(3):115-25.

29. Deenadayalu VP, Rex DK. Colon polyp retrieval after cold snaring.Gastrointest Endosc. 2005 Aug;62(2):253-6.

30. Kahi CJ, Rex DK. Screening and surveillance of colorectal cancer.Gastrointest Endosc Clin N Am. 2005 Jul;15(3):533-47, ix.

31. Subramanian S, Liangpunsakul S, Rex DK. Preprocedure patient values regarding sedation for colonoscopy.J Clin Gastroenterol. 2005 Jul;39(6):516-9.

32. Kessler WR, Rex DK. Impact of bending section length on insertion and retroflexion properties of pediatric and adult colonoscopes.Am J Gastroenterol. 2005 Jun;100(6):1290-5.

(31 OF 39)














33. Chen SC, Liangpunsakul S, Rex DK.

Watermelon colon treated by argon plasma coagulation.Gastrointest Endosc. 2005 Apr;61(4):631-3.

34. Rex DK, Khashab M, Raju GS, Pasricha J, Kozarek R. Insertability and safety of a shape-locking device for colonoscopy.Am J Gastroenterol. 2005 Apr;100(4):817-20.

35. Rex DK. Three challenges: propofol, colonoscopy by undertrained physicians, and CT colonography.Am J Gastroenterol. 2005 Mar;100(3):510-3.

36. Khashab M, Rex DK. Efficacy and tolerability of a new formulation of sodium phosphate tablets (INKP-101), and a reduced sodium phosphate dose, in colon cleansing: a single-center open-label pilot trial.Aliment Pharmacol Ther. 2005 Feb 15;21(4):465-8.

37. Subramanian S, Rex DK. Variable stiffness colonoscopes: do they offer a better examination?Curr Opin Gastroenterol. 2003 Sep;19(5):492-6.

38. Deenadayalu VP, Chadalawada V, Rex DK. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates.Am J Gastroenterol. 2004 Nov;99(11):2138-42.

39. Rex DK. The science and politics of propofol.Am J Gastroenterol. 2004 Nov;99(11):2080-3.

40. Chen SC, Goodwine B, Rex DK. Removal of embedded foreign bodies in the GI tract after endoscopic division by using laser light.Gastrointest Endosc. 2004 Oct;60(4):653-4.

41. Singh N, Harrison M, Rex DK. A survey of colonoscopic polypectomy practices among clinical gastroenterologists.Gastrointest Endosc. 2004 Sep;60(3):414-8.

42. Deenadayalu VP, Rex DK. Fecal-based DNA assays: a new, noninvasive approach to colorectal cancer screening.Cleve Clin J Med. 2004 Jun;71(6):497-503.

43. Rex DK, Rawl SM, Rabeneck L, Rex EK, Hamilton F. Colorectal cancer in African Americans.Rev Gastroenterol Disord. 2004 Spring;4(2):60-5.

44. Chen SC, Rex DK. An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.Am J Gastroenterol. 2004 Jun;99(6):1081-6.

45. Liangpunsakul S, Maglinte DD, Rex DK. Comparison of wireless capsule endoscopy and conventional radiologic methods in the diagnosis of small bowel disease.Gastrointest Endosc Clin N Am. 2004 Jan;14(1):43-50.

46. Harrison M, Singh N, Rex DK. Impact of proximal colon retroflexion on adenoma miss rates.Am J Gastroenterol. 2004 Mar;99(3):519-22.

(32 OF 39)















47. Ulmer BJ, Hansen JJ, Overley CA, Symms MR, Chadalawada V, Liangpunsakul S, Strahl E, Mendel AM, Rex DK.

Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists.Clin Gastroenterol Hepatol. 2003 Nov;1(6):425-32.

48. Kahi CJ, Rex DK. Current and future trends in colorectal cancer screening.Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):137-44.

49. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.Gastroenterology. 2003 Dec;125(6):1670-7.

50. Chen SC, Rex DK. Review article: registered nurse-administered propofol sedation for endoscopy.Aliment Pharmacol Ther. 2004 Jan 15;19(2):147-55.

Hong Shen



Stuart Sherman




4. Schmidt CM, Yip-Schneider MT, Ralstin MC, Wentz S, Dewitt J, Sherman S, Howard TJ, McHenry L, Dutkevitch S, Goggins M, Nakeeb A, Lillemoe KD.PGE(2) in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia.J Gastrointest Surg. 2007 Nov 20;.

5. LeBlanc JK, DeWitt J, Sherman S. Endoscopic ultrasound: how does it aid the surgeon?Adv Surg. 2007;41:17-50.

(33 OF 39)














6. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik

FM, Sherman S, Pitt HA, Lillemoe KD.Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4.


8. Sandrasegaran K, Tann M, Jennings SG, Maglinte DD, Peter SD, Sherman S, Howard TJ. Disconnection of the pancreatic duct: an important but overlooked complication of severe acute pancreatitis.Radiographics. 2007 Sep-Oct;27(5):1389-400.



11. Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.Clin Gastroenterol Hepatol. 2007 Apr;5(4):489-95.

12. DeWitt J, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of ascites.Clin Gastroenterol Hepatol. 2007 May;5(5):609-15.







(34 OF 39)















19. Yimcharoen P, Fogel EL, Kovacs RJ, Rosenfeld SH, McHenry L, Watkins JL, Alazmi WM, Sherman S, Lehman GA.

Droperidol, when used for sedation during ERCP, may prolong the QT interval.Gastrointest Endosc. 2006 Jun;63(7):979-85.

20. Akisik MF, Sandrasegaran K, Aisen AA, Maglinte DD, Sherman S, Lehman GA. Dynamic secretin-enhanced MR cholangiopancreatography.Radiographics. 2006 May-Jun;26(3):665-77.








28. Lim WC, Leblanc JK, Chappo JM, Howard TJ, Sherman S. Pancreatic mucinous adenocarcinoma with peritoneal metastases.Gastrointest Endosc. 2005 Jul;62(1):140-1.

29. DeWitt J, McGreevy K, LeBlanc J, McHenry L, Cummings O, Sherman S. EUS-guided Trucut biopsy of suspected nonfocal chronic pancreatitis.Gastrointest Endosc. 2005 Jul;62(1):76-84.

30. Fogel EL, Sherman S. Abdominal pain with fluctuating elevation of amylase and AST.Clin Gastroenterol Hepatol. 2005 Jun;3(6):538-42.

31. Madura JA, Madura JA 2nd, Sherman S, Lehman GA. Surgical sphincteroplasty in 446 patients.Arch Surg. 2005 May;140(5):504-11; discussion 511-3.

(35 OF 39)

















32. DeWitt J, Jowell P, Leblanc J, McHenry L, McGreevy K, Cramer H, Volmar K, Sherman S, Gress F.

EUS-guided FNA of pancreatic metastases: a multicenter experience.Gastrointest Endosc. 2005 May;61(6):689-96.

33. DeWitt J, Kesler K, Brooks JA, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.Dis Esophagus. 2005;18(1):21-7.







40. LeBlanc J, Youssef W, DeWitt J, Sherman S, Chappo J, McHenry L. Metastatic breast cancer to the gastroesophageal junction 14 years after radical mastectomy.Gastrointest Endosc. 2004 May;59(6):733-6.


42. LeBlanc JK, Ciaccia D, Al-Assi MT, McGrath K, Imperiale T, Tao LC, Vallery S, DeWitt J, Sherman S, Collins E. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis.Gastrointest Endosc. 2004 Apr;59(4):475-81.

43. Madura JA, Yum MN, Lehman GA, Sherman S, Schmidt CM. Mucin secreting cystic lesions of the pancreas: treatment by enucleation.Am Surg. 2004 Feb;70(2):106-12; discussion 113.

44. Dewitt J, Youssef W, Leblanc J, McHenry L, McGreevy K, Chappo J, Cramer H, Sherman S. EUS-guided FNA of a thyroid mass.Gastrointest Endosc. 2004 Feb;59(2):307-10.

(36 OF 39)
















45. Dewitt J, McHenry L, Fogel E, Leblanc J, McGreevy K, Sherman S.

EUS-guided methylene blue pancreatography for minor papilla localization after unsuccessful ERCP.Gastrointest Endosc. 2004 Jan;59(1):133-6.

46. Rashdan A, Fogel E, McHenry L Jr, Lehman G, Sherman S. Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction.Gastrointest Endosc. 2003 Dec;58(6):875-8.

47. Devereaux BM, LeBlanc JK, Kesler K, Brooks J, Lehman GA, Sherman S, Ciaccia D. Giant fibrovascular polyp of the esophagus.Endoscopy. 2003 Nov;35(11):970-2.

48. Dewitt J, Ghorai S, Kahi C, Leblanc J, McHenry L, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S. EUS-FNA of recurrent postoperative extraluminal and metastatic malignancy.Gastrointest Endosc. 2003 Oct;58(4):542-8.


50. DeWitt J, LeBlanc J, McHenry L, Ciaccia D, Imperiale T, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience.Am J Gastroenterol. 2003 Sep;98(9):1976-81.

Raj K. Vuppalanchi

1. Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93.

2. Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, Bansal N, Chalasani N. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.J Clin Gastroenterol. 2007 Feb;41(2):206-10.


4. Vuppalanchi R, Vakili ST, Kahi CJ. Isolated melanosis of the gastric antrum: an unusual endoscopic finding.Clin Gastroenterol Hepatol. 2007 Jan;5(1):e2.

5. Vuppalanchi R, Chalasani N, Saxena R. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.Am J Surg Pathol. 2006 Dec;30(12):1619-23.

6. Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85.

7. Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.J Clin Gastroenterol. 2005 Mar;39(3):237-42.

(37 OF 39)














8. Vuppalanchi R, Teal E, Chalasani N.

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.Am J Med Sci. 2005 Feb;329(2):62-5.

James L. Watkins












(38 OF 39)














12. Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS,

Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA.Risk factors for post-ERCP pancreatitis: a prospective multicenter study.Am J Gastroenterol. 2006 Jan;101(1):139-47.








20. Park SH, Watkins JL, Fogel EL, Sherman S, Lazzell L, Bucksot L, Lehman GA. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.Gastrointest Endosc. 2003 Apr;57(4):483-91.

(39 OF 39)














Documents

IU GI FACULTY – PUBLICATIONS LAST 5 YEARS